Emergent Biosolutions Inc. buy Benchmark Co.
Start price
10.04.23
/
50%
€11.36
Target price
10.04.24
€20.27
Performance (%)
-82.04%
End price
11.04.24
€2.04
Summary
This prediction ended on 11.04.24 with a price of €2.04. Massive losses of -82.04% were the result for the BUY prediction by Benchmark_Co_. Benchmark_Co_ has a follow-up prediction for Emergent Biosolutions Inc. where he still thinks Emergent Biosolutions Inc. is a Buy. Benchmark_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Emergent Biosolutions Inc. | -5.785% | -5.785% | -77.562% |
| iShares Core DAX® | 2.594% | -1.861% | 13.242% |
| iShares Nasdaq 100 | 3.553% | -2.064% | 38.293% |
| iShares Nikkei 225® | 0.687% | -8.704% | 17.510% |
| iShares S&P 500 | 2.209% | -1.988% | 27.632% |
Comments by Benchmark_Co_ for this prediction
In the thread Emergent Biosolutions Inc. diskutieren
Emergent BioSolutions Inc. (NYSE: EBS) was upgraded by analysts at Benchmark Co. from a "hold" rating to a "buy" rating. They now have a $22.00 price target on the stock.
Ratings data for EBS provided by MarketBeat
In the thread Trading Emergent Biosolutions Inc.
Die von Benchmark_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.53
07.03.24
07.03.24
€4.58
07.03.25
07.03.25
-28.76%
26.04.24
26.04.24
Stopped prediction by Benchmark_Co_ for Emergent Biosolutions Inc.
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€2.04
11.04.24
11.04.24
€4.65
11.04.25
11.04.25
-11.79%
26.04.24
26.04.24